Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 16 of 16 results for omalizumab

  1. 'Life changing' treatment approved for people with severe asthma

    Omalizumab (Xolair) is now available for NHS patients as an add-on treatment for severe, persistent allergic asthma in adults, adolescents and children, says NICE.

    News
    Published
    24 April 2013